Will soon make final analysis of Covaxin efficacy trials public, says Bharat Biotech

As the clamour grows for Bharat Biotech to publish the phase-III data for indigenously developed Covaxin, the company said it is committed to data transparency and will soon be making the final analysis data of the efficacy trials public.

Original source: https://health.economictimes.indiatimes.com/news/pharma/83475985?utm_source=RSS&utm_medium=ETRSS

Related Posts